Cyclophosphamide (CPM) and melphalan (MEL) for recurrent medulloblastoma (MB) and intracranial germinoma (GCT) - A Children's Oncology Group (COG) study
Publication
, Journal Article
Kadota, R; Mahoney, DH; Doyle, J; Duerst, R; Friedman, HS; Holmes, EJ; Kun, LE; Zhou, T; Pollack, IE
Published in: PEDIATRIC BLOOD & CANCER
October 1, 2007
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
PEDIATRIC BLOOD & CANCER
DOI
ISSN
1545-5009
Publication Date
October 1, 2007
Volume
49
Issue
4
Start / End Page
422 / 422
Publisher
WILEY-LISS
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kadota, R., Mahoney, D. H., Doyle, J., Duerst, R., Friedman, H. S., Holmes, E. J., … Pollack, I. E. (2007). Cyclophosphamide (CPM) and melphalan (MEL) for recurrent medulloblastoma (MB) and intracranial germinoma (GCT) - A Children's Oncology Group (COG) study. PEDIATRIC BLOOD & CANCER, 49(4), 422–422. https://doi.org/10.1002/pbc
Kadota, Richard, D. H. Mahoney, J. Doyle, R. Duerst, H. S. Friedman, E. J. Holmes, L. E. Kun, T. Zhou, and I. E. Pollack. “Cyclophosphamide (CPM) and melphalan (MEL) for recurrent medulloblastoma (MB) and intracranial germinoma (GCT) - A Children's Oncology Group (COG) study.” PEDIATRIC BLOOD & CANCER 49, no. 4 (October 1, 2007): 422–422. https://doi.org/10.1002/pbc.
Kadota R, Mahoney DH, Doyle J, Duerst R, Friedman HS, Holmes EJ, et al. Cyclophosphamide (CPM) and melphalan (MEL) for recurrent medulloblastoma (MB) and intracranial germinoma (GCT) - A Children's Oncology Group (COG) study. PEDIATRIC BLOOD & CANCER. 2007 Oct 1;49(4):422–422.
Kadota, Richard, et al. “Cyclophosphamide (CPM) and melphalan (MEL) for recurrent medulloblastoma (MB) and intracranial germinoma (GCT) - A Children's Oncology Group (COG) study.” PEDIATRIC BLOOD & CANCER, vol. 49, no. 4, WILEY-LISS, Oct. 2007, pp. 422–422. Wos, doi:10.1002/pbc.
Kadota R, Mahoney DH, Doyle J, Duerst R, Friedman HS, Holmes EJ, Kun LE, Zhou T, Pollack IE. Cyclophosphamide (CPM) and melphalan (MEL) for recurrent medulloblastoma (MB) and intracranial germinoma (GCT) - A Children's Oncology Group (COG) study. PEDIATRIC BLOOD & CANCER. WILEY-LISS; 2007 Oct 1;49(4):422–422.
Published In
PEDIATRIC BLOOD & CANCER
DOI
ISSN
1545-5009
Publication Date
October 1, 2007
Volume
49
Issue
4
Start / End Page
422 / 422
Publisher
WILEY-LISS
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences